The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection
Open accessAbstract
Significance: This work showed that a designed cyclic peptide ZY4 exhibits excellent activity against Pseudomonas aeruginosa and Acinetobacter baumannii . ZY4 not only inhibits planktonic growth and biofilm formation but also kills persister cells by permeabilizing bacterial membrane. ZY4 showed low propensity to induce resistance, high stability in vivo, and therapeutic potentials in MDR P. aeruginosa – and A. baumannii –induced infection. The present study provides a promising drug candidate in the war against multidrug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
The drug-resistant bacteria that pose the greatest health threats
Willyard, C. (2017) · Nature · doi:10.1038/nature.2017.21550 · Cited by 1,221
Persister cells and tolerance to antimicrobials
Keren, I., Kaldalu, N., Spoering, A., Wang, Y., & Lewis, K. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00856-5 · Cited by 1,098
Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action
Chan, D. I., Prenner, E. J., & Vogel, H. J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.04.006 · Cited by 1,039
Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control
Percival, S. L., Suleman, L., Vuotto, C., & Donelli, G. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000032 · Cited by 736
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms
de Breij, A., Riool, M., Cordfunke, R. A., Malanovic, N., de Boer, L., Koning, R. I., Ravensbergen, E., Franken, M., van der Heijde, T., Boekema, B. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4044 · Cited by 555 · cited 3×
“Increasing evidence also suggests that several Trp/Arg-containing AMPs were able to kill persister cells (12, 33, 40).”
Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii
Geisinger, E., & Isberg, R. R. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004691 · Cited by 548
Rasamiravaka, T., Labtani, Q., Duez, P., & El Jaziri, M. (2015) · BioMed Research International · doi:10.1155/2015/759348 · Cited by 546
Rapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase
Loeffler, J. M., Nelson, D., & Fischetti, V. A. (2001) · Science · doi:10.1126/science.1066869 · Cited by 517
Fauvart, M., De Groote, V. N., & Michiels, J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030932-0 · Cited by 425
Interaction of Cationic Antimicrobial Peptides with Model Membranes
Zhang, L., Rozek, A., & Hancock, R. E. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104925200 · Cited by 410
Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria
Batoni, G., Maisetta, G., & Esin, S. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.013 · Cited by 401
Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells
Pu, Y., Zhao, Z., Li, Y., Zou, J., Ma, Q., Zhao, Y., Ke, Y., Zhu, Y., Chen, H., Baker, M. A. B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.035 · Cited by 381
Self-citationAntimicrobial Peptides: Properties and Applicability
Hof, W. V. T., Veerman, E. C. I., Helmerhorst, E. J., & Amerongen, A. V. N. (2001) · Biological Chemistry · doi:10.1515/bc.2001.072 · Cited by 354
Nathwani, D., Raman, G., Sulham, K., Gavaghan, M., & Menon, V. (2014) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-3-32 · Cited by 344
Antimicrobial peptides: new hope in the war against multidrug resistance
Mwangi, J., Hao, X., Lai, R., & Zhang, Z.-Y. (2019) · Zool. Res. · doi:10.24272/j.issn.2095-8137.2019.062 · Cited by 289
Self-citationYao, Y., Sturdevant, D. E., & Otto, M. (2005) · The Journal of Infectious Diseases · doi:10.1086/426945 · Cited by 268
Deslouches, B., Phadke, S. M., Lazarevic, V., Cascio, M., Islam, K., Montelaro, R. C., & Mietzner, T. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.316-322.2005 · Cited by 262
Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm
Dunne, W. M., Mason, E. O., & Kaplan, S. L. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.12.2522 · Cited by 255
Snake Cathelicidin from Bungarus fasciatus Is a Potent Peptide Antibiotics
Wang, Y., Hong, J., Liu, X., Yang, H., Liu, R., Wu, J., Wang, A., Lin, D., & Lai, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003217 · Cited by 246
Self-citationDathe, M., Nikolenko, H., Klose, J., & Bienert, M. (2004) · Biochemistry · doi:10.1021/bi035948v · Cited by 186
Tomczyk, S., Zanichelli, V., Grayson, M. L., Twyman, A., Abbas, M., Pires, D., Allegranzi, B., & Harbarth, S. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy752 · Cited by 173
Grassi, L. C., Luca, M. D., Maisetta, G., Rinaldi, A. C., Esin, S., Trampuž, A., & Batoni, G. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01917 · Cited by 151
Charge distribution and imperfect amphipathicity affect pore formation by antimicrobial peptides
Mihajlovic, M., & Lazaridis, T. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.01.016 · Cited by 134
Jin, L., Bai, X., Luan, N., Yao, H., Zhang, Z., Liu, W., Chen, Y., Yan, X., Rong, M., Lai, R., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01264 · Cited by 130
Self-citationWang, Y., Zhang, Z., Chen, L., Guang, H., Li, Z., Yang, H., Li, J., You, D., Yu, H., & Lai, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022120 · Cited by 101
Self-citationRajasekaran, G., Kim, E. Y., & Shin, S. Y. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.01.037 · Cited by 101
Control of Bacterial Persister Cells by Trp/Arg-Containing Antimicrobial Peptides
Chen, X., Zhang, M., Zhou, C., Kallenbach, N. R., & Ren, D. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.02440-10 · Cited by 95
Ilić, N., Novković, M., Guida, F., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.11.017 · Cited by 85
Antimalarial Peptides: The Long and the Short of It
Bell, A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797416057 · Cited by 69
Pseudomonas aeruginosa bloodstream infections: how should we treat them?
van Delden, C. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.06.015 · Cited by 66
A Small Peptide with Therapeutic Potential for Inflammatory Acne Vulgaris
Zhang, Z., Mu, L., Tang, J. Y., Duan, Z., Wang, F., Wei, L., Rong, M., & Lai, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072923 · Cited by 41
Self-citationAntimicrobial Peptides as Anti-Infectives against Staphylococcus epidermidis
Agarwal, S., Sharma, G., Dang, S., Gupta, S., & Gabrani, R. (2015) · Medical Principles and Practice · doi:10.1159/000443479 · Cited by 33
Pathogenesis of cystic fibrosis airways disease.
Boucher, R. (2001) · PubMed Central · Cited by 25
Antimicrobial Peptides: A Potential Therapeutic Option for Surgical Site Infections.
Deslouches, B., & Di, Y. P. (2017) · PubMed · Cited by 23
Cited by
Antimicrobial peptides for combating drug-resistant bacterial infections
Xuan, J., Feng, W., Wang, J., Wang, R., Zhang, B., Bo, L., Chen, Z.-S., Yang, H., & Sun, L. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100954 · Cited by 665
Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Antimicrobial Peptides: A Potent Alternative to Antibiotics
Rima, M., Rima, M., Fajloun, Z., Sabatier, J.-M., Bechinger, B., & Naas, T. (2021) · Antibiotics · doi:10.3390/antibiotics10091095 · Cited by 350
Balasubramaniam, B., Prateek, Ranjan, S., Saraf, M., Kar, P., Singh, S. P., Thakur, V. K., Singh, A., & Gupta, R. K. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00174 · Cited by 285
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Wood, S. J., Kuzel, T. M., & Shafikhani, S. H. (2023) · Cells · doi:10.3390/cells12010199 · Cited by 254
Metadata
- Authors
- Mwangi, J., Yin, Y., Wang, G., Yang, M., Li, Y., Zhang, Z., & Lai, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2019-12-16
- Volume
- 116
- Issue
- 52
- Pages
- 26516-26522
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2994634742
- Cited by
- 286
- References
- 41
- FWCI
- 21.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.